BRIEF-3D signatures plans to announce clinical trial for Hodgkin's Lymphoma precision medicine test in coming months

Mon Oct 17, 2016 10:09am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 17 (Reuters) - 3d Signatures Inc :

* 3DS plans to announce a clinical trial for a Hodgkin's Lymphoma precision medicine test in coming months

* Expects to engage laboratory partner in validation, approval of a Hodgkin's Lymphoma Laboratory Developed Test (LDT) for Canada in 2017 Source text for Eikon: Further company coverage: